Cholecystokinin, behavioral tolerance and tumor-induced anorexia.
Cholecystokinin octapeptide (CCK-8, 5 micrograms/kg, IP) was injected daily, for two 4-day periods, into rats bearing the Walker 256 carcinosarcoma (TB) and non-tumor bearing (NTB) control animals. All animals were on a 20 hr food and water deprivation schedule and monitored for food and water intake and bodyweight for 4 hr daily. Food intake was significantly reduced by the daily administration of CCK. Behavioral tolerance to CCK was not observed in either the NTB or TB rats. These results indicate that the parameters describing the phenomenon of behavioral tolerance to CCK are yet to be clearly defined and that peptides other than CCK may underlie the mechanism primarily responsible for producing anorexia associated with cancer.
Sleeman
M
M
Willis
G L
GL
Smith
G C
GC
D000818:Animals; D000855:Anorexia / Q000503:physiopathology*; D002279:Carcinoma 256, Walker / Q000503:physiopathology*; D004327:Drinking Behavior / Q000187:drug effects*; D004361:Drug Tolerance; D005247:Feeding Behavior / Q000187:drug effects*; D001068:Feeding and Eating Disorders / Q000503:physiopathology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012844:Sincalide / Q000494:pharmacology*
D012844:Sincalide